$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
卡博替尼治疗甲状腺髓样癌的临床评价
2025-10-19 11:44:20
Check Details
甲状腺肿大与甲状腺癌的区别
2025-10-19 11:44:20
Check Details
卡博替尼治疗碘难治分化型甲状腺癌研究
2025-10-19 11:44:20
Check Details
甲状腺癌的早期症状有哪些?
2025-10-19 11:44:20
Check Details
卡博替尼用于转移性甲状腺髓样癌(MTC)患者的治疗
2025-10-19 11:44:20
Check Details
甲状腺癌在生活中如何预防?
2025-10-19 11:44:20
Check Details
索拉非尼延长分化型甲状腺癌患者的生存期
2025-10-19 11:44:20
Check Details
新药获甲状腺髓样癌和非小细胞肺癌突破两项性疗法认定
2025-10-19 11:44:20
Check Details
甲状腺癌患者淋巴结阳性与其年龄有关
2025-10-19 11:44:20
Check Details
乐伐替尼治疗甲状腺癌安全有效
2025-10-19 11:44:20
Check Details
甲状腺癌的治疗方法有哪些?
2025-10-19 11:44:20
Check Details
甲状腺癌治疗方式有哪些?
2025-10-19 11:44:20
Check Details
1
2
...
2438
2439
2440
2441
2442
2443
2444
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
2
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
5
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
6
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
7
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
8
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
9
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
10
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
11
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
12
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments